Study: Daniel 2013, Journal of Drugs in Dermatology
Shave frequency and regimen variation effects on the management of pseudofolliculitis barbae
Citation
Daniel A, Gustafson CJ, Zupkosky PJ, Candido A et al (2013). Journal of Drugs in Dermatology. PubMed id 23652888.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Shaving and razor bumps (pseudofolliculitis barbae) Tier A thin
A 90 African American men with pseudofolliculitis barbae (PFB) (n=90)
Randomised to three groups for 12 weeks: shaving 2-3 times a week with standard products, daily with standard products, or daily with advanced products.
Papule and pustule counts did not differ between groups at 12 weeks, and investigator-graded severity did not differ (P=.43). Ingrown hairs were significantly fewer in the 2-3 times a week group than in either daily group (P=.005 against daily standard, P=.04 against daily advanced). Participants in the daily advanced products group reported more perceived improvement (P=.007) and less itching (P=.002) than the 2-3 times a week group.
As recorded in this card: Daniel A, Gustafson CJ, Zupkosky PJ, Candido A et al (2013), Journal of Drugs in Dermatology, [primary]
Note: V2 check against the abstract (efetch, 12 Nov 2026): papule and pustule counts did not differ between groups (P=.32, P=.46); ingrown hairs were fewer in the 2-3 times a week group than in either daily group (P=.005, P=.04); investigator severity did not differ (P=.43). The daily "advanced products" group reported better perceived response (P=.007) and itching (P=.002) than the 2-3 times a week group. The abstract names no product or razor type, so it cannot support single-blade or razor-guard advice. Funding not stated.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.